For: | Dong M, Zhou JP, Zhang H, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(18): 2744-2747 [PMID: 15884114 DOI: 10.3748/wjg.v11.i18.2744] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i18/2744.htm |
Number | Citing Articles |
1 |
Sridharan Jeyamohan, Rajesh Kannan Moorthy, Mahesh Kumar Kannan, Antony Joseph Velanganni Arockiam. Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer. Biotechnology Letters 2016; 38(8): 1251 doi: 10.1007/s10529-016-2102-7
|
2 |
Parisa Bazsefidpar, Shabnaz Koochakkhani, Behnaz Rahnama Inchehsablagh, Ebrahim Eftekhar, Elahe Aliasgari. Tin (IV) Oxide (SnO2) Nanoparticles Inhibit the Viability of Cervical Cancer HeLa Cells Through Induction of Apoptosis. Journal of Reports in Pharmaceutical Sciences 2021; 10(2): 225 doi: 10.4103/jrptps.JRPTPS_109_20
|
3 |
Richard A. Smith, Jane V. Butler, John P. Neoptolemos. Patient Surveillance After Cancer Treatment. 2013; : 129 doi: 10.1007/978-1-60327-969-7_24
|
4 |
Daniel Ansari, William Torén, Qimin Zhou, Dingyuan Hu, Roland Andersson. Proteomic and genomic profiling of pancreatic cancer. Cell Biology and Toxicology 2019; 35(4): 333 doi: 10.1007/s10565-019-09465-9
|
5 |
Yan Shen, Minxia Cai, Weiliang Xia, Junwei Liu, Qiyi Zhang, Haiyang Xie, Chen Wang, Xiaohui Wang, Shusen Zheng. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells. Cancer Letters 2007; 254(2): 288 doi: 10.1016/j.canlet.2007.03.013
|
6 |
Randall J Kimple, Suzanne Russo, Arta Monjazeb, A William Blackstock. The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer. Expert Review of Anticancer Therapy 2012; 12(4): 469 doi: 10.1586/era.12.18
|
7 |
Cuiyue Wang, Zhen Feng, Kaitong Jiang, Xiuli Zuo. [ARTICLE WITHDRAWN] Upregulation of MicroRNA-935 Promotes the Malignant Behaviors of Pancreatic Carcinoma PANC-1 Cells via Targeting Inositol Polyphosphate 4-Phosphatase Type I Gene (INPP4A). Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(4): 559 doi: 10.3727/096504016X14759554689565
|
8 |
Filippo Pietrantonio, Pamela Biondani, Elisa Ciurlia, Giuseppe Fanetti, Anna Tessari, Gaia Bertarelli, Ilaria Bossi, Valeria Musella, Flavia Melotti, Maria Di Bartolomeo, Francesca Valvo, Alessandro Pellegrinelli, Massimo Milione, Federica Perrone, Filippo de Braud. Role of BAX for outcome prediction in gastrointestinal malignancies. Medical Oncology 2013; 30(3) doi: 10.1007/s12032-013-0610-z
|
9 |
D Ansari, A Rosendahl, J Elebro, R Andersson. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. British Journal of Surgery 2011; 98(8): 1041 doi: 10.1002/bjs.7574
|
10 |
Nigel B. Jamieson, C. Ross Carter, Colin J. McKay, Karin A. Oien. Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. Clinical Cancer Research 2011; 17(10): 3316 doi: 10.1158/1078-0432.CCR-10-3284
|
11 |
Giuseppe Tonini, Francesco Pantano, Bruno Vincenzi, Armando Gabbrielli, Roberto Coppola, Daniele Santini. Molecular prognostic factors in patients with pancreatic cancer. Expert Opinion on Therapeutic Targets 2007; 11(12): 1553 doi: 10.1517/14728222.11.12.1553
|
12 |
R A Smith, J Tang, C Tudur-Smith, J P Neoptolemos, P Ghaneh. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of Cancer 2011; 104(9): 1440 doi: 10.1038/bjc.2011.110
|
13 |
Xue Sun, Siyuan Wang, Catherine C.L. Wong. Mass spectrometry–based proteomics technology in pancreatic cancer research. Journal of Pancreatology 2024; 7(2): 145 doi: 10.1097/JP9.0000000000000152
|